AbCellera Biologics Inc. (ABCL) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$55.79M; Operating income (m); Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA -$50.68M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$76.28M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA -$44.12M; Operating income (m); Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2025-03-31 to 2026-06-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$55.79M | (m) | (m) | (m) | -1377.46% | $2.13M* | $25.92M* | (m) | $45.99M | $13.85M | -$3.54M |
|---|
| 2026-03-31 | Reported | -$50.68M | (m) | (m) | (m) | -609.51% | $3.83M | -$33.52M | (m) | $46.66M | $12.33M | -$6.37M |
|---|
| 2025-09-30 | Reported | (m) | -$76.28M | (m) | $8.96M | (m) | $8.93M* | -$52.59M* | (m) | $55.03M | (m) | -$11.65M |
|---|
| 2025-06-30 | Reported | -$44.12M | (m) | (m) | (m) | -258.22% | $13.37M* | -$32.40M* | (m) | $39.21M | $21.99M | -$1.62M |
|---|
| 2025-03-31 | Reported | -$57.33M | (m) | (m) | (m) | -1353.70% | $10.64M | -$11.55M | (m) | $42.50M | $19.07M | -$7.36M |
|---|
| 2024-09-30 | Reported | (m) | -$93.66M | (m) | $6.51M | (m) | $18.52M* | -$28.88M* | (m) | $40.97M | (m) | -$11.53M |
|---|
| 2024-06-30 | Reported | (m) | -$93.45M | (m) | $7.32M | (m) | $20.11M* | -$29.97M* | (m) | $40.93M | (m) | -$11.26M |
|---|
| 2024-03-31 | Reported | (m) | -$54.89M | (m) | $9.95M | (m) | $24.14M | -$41.71M | (m) | $39.29M | (m) | -$2.14M |
|---|
| 2023-09-30 | Reported | (m) | -$54.89M | (m) | $6.60M | (m) | $20.33M* | -$106.00K* | (m) | $37.92M | (m) | -$10.67M |
|---|
| 2023-06-30 | Reported | (m) | -$51.39M | (m) | $10.06M | (m) | $27.20M* | $19.90M* | (m) | $36.47M | (m) | -$7.48M |
|---|
| 2023-03-31 | Reported | (m) | -$64.87M | (m) | $12.19M | (m) | $14.98M | -$44.06M | (m) | $52.65M | (m) | -$8.04M |
|---|
| 2022-09-30 | Reported | (m) | $37.73M | (m) | $101.38M | (m) | $12.51M* | -$126.79M* | (m) | $26.58M | (m) | $19.96M |
|---|
| 2022-06-30 | Reported | (m) | -$8.40M | (m) | $45.92M | (m) | $31.32M* | $273.01M* | (m) | $26.68M | (m) | -$101.00K |
|---|
| 2022-03-31 | Reported | (m) | $224.95M | (m) | $316.58M | (m) | $14.49M | $100.22M | (m) | $26.37M | (m) | $62.24M |
|---|
| 2021-09-30 | Reported | (m) | -$28.10M | (m) | $5.51M | (m) | $8.57M* | -$5.93M* | (m) | $17.45M | (m) | -$3.59M |
|---|
| 2021-06-30 | Reported | (m) | -$7.03M | (m) | $27.64M | (m) | $36.80M* | $157.68M* | (m) | $15.05M | (m) | $250.00K |
|---|
| 2021-03-31 | Reported | (m) | $158.07M | (m) | $202.74M | (m) | $3.64M | $109.55M | (m) | $12.35M | (m) | $44.27M |
|---|
| 2020-09-30 | Reported | (m) | -$1.77M | (m) | $9.36M | (m) | $3.88M* | -$3.80M* | (m) | $7.50M | (m) | (m) |
|---|
| 2020-06-30 | Reported | (m) | -$854.00K | (m) | $11.23M | (m) | $3.70M* | $25.98M* | (m) | $9.14M | (m) | (m) |
|---|
| 2020-03-31 | Reported | (m) | -$2.12M | (m) | $4.66M | (m) | $583.00K | -$764.00K | (m) | $4.12M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | -$217.10M | (m) | $75.13M | (m) | $42.77M | -$131.29M | (m) | $186.83M | (m) | -$31.18M |
|---|
| 2024-12-31 | Reported | (m) | -$314.77M | (m) | $28.83M | (m) | $78.40M | -$108.56M | (m) | $167.26M | (m) | -$37.54M |
|---|
| 2023-12-31 | Reported | (m) | -$237.21M | (m) | $38.02M | (m) | $76.95M | -$43.88M | (m) | $175.66M | (m) | -$27.63M |
|---|
| 2022-12-31 | Reported | (m) | $216.51M | (m) | $485.42M | (m) | $70.66M | $277.36M | (m) | $107.88M | (m) | $80.58M |
|---|
| 2021-12-31 | Reported | (m) | $204.41M | (m) | $375.20M | (m) | $58.45M | $244.58M | (m) | $62.06M | (m) | $65.69M |
|---|
| 2020-12-31 | Reported | (m) | $156.03M | (m) | $233.16M | (m) | $9.67M | $22.69M | (m) | $29.39M | (m) | $38.91M |
|---|
| 2019-12-31 | Reported | (m) | -$4.12M | (m) | $11.61M | (m) | $4.00M | $2.69M | (m) | $10.11M | (m) | (m) |
|---|